intestin
infect
enterotoxigen
escherichia
coli
etec
import
diseas
swine
result
signific
econom
loss
knowledg
epidemiolog
diagnost
approach
method
control
fundament
import
tackl
diseas
etec
caus
neonat
colibacillosi
mostli
carri
fimbria
etec
postwean
diarrhoea
carri
fimbria
fimbria
adher
specif
receptor
porcin
intestin
brush
border
epitheli
cell
enterocyt
start
process
enter
infect
colon
bacteria
produc
one
enterotoxin
induc
diarrhoea
heat
stabl
toxin
sta
heat
stabl
toxin
b
stb
heat
labil
toxin
lt
role
pathogenesi
diseas
demonstr
toxin
diagnosi
enter
colibacillosi
base
isol
quantif
pathogen
ecoli
coupl
demonstr
pcr
gene
encod
virul
factor
fimbria
toxin
diagnost
approach
enter
colibacillosi
must
consid
differenti
diagnosi
potenti
differ
caus
involv
outbreak
among
differ
method
control
colibacillosi
use
antimicrobi
wide
practic
antibiot
use
two
main
way
prophylact
metaphylact
treatment
prevent
diseas
therapeut
purpos
treat
diseas
pig
accur
diagnosi
enter
colibacillosi
need
appropri
sampl
isol
quantif
etec
respons
outbreak
use
semiquantit
bacteriolog
definit
diagnosi
base
presenc
characterist
lesion
result
bacteriolog
along
confirm
appropri
virul
factor
identifi
isol
ecoli
import
confirm
diagnosi
perform
antimicrobi
sensit
test
antimicrobi
sensit
vari
greatli
among
e
coli
isol
grow
concern
increas
antimicrobi
resist
forc
ration
use
antibiot
achiev
correct
understand
issu
relat
antibiot
therapi
use
antibiot
practition
farmer
escherichia
coli
gram
neg
peritrich
flagel
bacteria
belong
famili
enterobatteriacea
caus
agent
wide
rang
diseas
pig
includ
neonat
diarrhoea
postwean
diarrhoea
pwd
import
caus
death
occur
worldwid
suckl
wean
pig
respect
two
main
pathotyp
involv
enter
colibacillosi
enterotoxigen
ecoli
etec
enteropathogen
ecoli
epec
etec
import
pathotyp
swine
includ
differ
virotyp
term
use
describ
strain
character
differ
combin
toxin
fimbria
outbreak
neonat
postwean
diarrhoea
due
etec
infect
gener
affect
high
proport
pig
often
recurr
herd
requir
expens
control
measur
enter
colibacillosi
may
result
signific
econom
loss
due
mortal
decreas
weight
gain
cost
treatment
vaccin
feed
supplement
depend
sever
diseas
cost
pwd
estim
rang
per
sow
etec
possess
fimbria
adher
enterocyt
elabor
one
sever
enterotoxin
fig
induc
secretori
diarrhoea
caus
signific
diseas
pig
industri
worldwid
neonat
colibacillosi
pwd
strategi
commonli
use
prevent
control
neonat
colibacillosi
aim
reduc
number
pathogen
ecoli
environ
implement
hygien
measur
intern
extern
biosecur
mainten
suitabl
environment
condit
piglet
high
level
immun
guarante
lactogen
immun
vaccin
sow
etec
reduc
risk
diseas
develop
variou
approach
use
prevent
etec
pwd
includ
passiv
administr
specif
antibodi
dietari
supplement
prebiot
probiot
dietari
prevent
measur
genet
breed
etecresist
herd
live
oral
nontoxigen
ecoli
vaccin
even
prevent
approach
report
neonat
postwean
colibacillosi
shown
promis
efficaci
antibiot
still
frequent
use
treat
enter
colibacillosi
administ
parenter
oral
rout
underdos
frequent
oral
administr
pig
condit
favour
select
resist
bacteria
antimicrobi
commonli
use
treat
enter
colibacillosi
must
chosen
abil
achiev
therapeut
concentr
intestin
content
frequent
use
enrofloxacin
apramycin
ceftiofur
neomycin
gentamicin
amoxicillinclavulan
acid
trimethoprimsulphonamid
colistin
antimicrobi
resist
apramycin
neomycin
trimethoprimsulfonimid
colistin
increasingli
observ
particular
etec
strain
caus
pwd
manag
enter
colibacillosi
pig
requir
understand
pathotyp
virotyp
ecoli
involv
condit
capabl
caus
diseas
order
implement
appropri
diagnost
strategi
prevent
control
key
element
approach
outbreak
colibacillosi
order
reach
reliabl
accur
diagnosi
knowledg
diagnost
process
interpret
criteria
diagnost
method
paper
aim
address
major
question
frequent
ask
face
etec
enter
neonat
postwean
colibacillosi
field
main
subject
review
concern
diagnost
approach
interpret
specif
investig
measur
control
base
antibiot
therapi
impact
antimicrobi
resist
control
diseas
neonat
enter
colibacillosi
etec
caus
neonat
enter
colibacillosi
enter
anim
ingest
presenc
predispos
environment
condit
host
factor
prolifer
intestin
caus
diseas
mean
specif
virul
factor
degre
colon
prolifer
determin
whether
diseas
result
infect
etec
respons
neonat
diarrhoea
possess
adhesin
surfac
protein
call
fimbria
identifi
fig
fimbria
allow
microorgan
adher
specif
receptor
brush
border
small
intestin
enterocyt
etec
fimbria
colon
length
jejunum
ileum
etec
fimbria
mostli
colon
posterior
jejunum
ileum
suscept
etec
decreas
age
relat
reduct
number
activ
receptor
present
intestin
epitheli
cell
age
etec
strain
neonat
colibacillosi
produc
heat
stabl
enterotoxin
sta
bind
guanylyl
cyclas
c
glycoprotein
receptor
brush
border
villou
crypt
intestin
epitheli
cell
stimul
product
cyclic
guanosin
monophosph
cgmp
lead
electrolyt
end
fluid
secret
excess
secret
lead
dehydr
eventu
death
metabol
acidosi
defin
state
decreas
system
ph
sever
complic
neonat
colibacillosi
due
lactat
product
clinic
sign
formerli
attribut
acidosi
fact
due
elev
blood
level
dlactat
sourc
dlactataemia
bacteri
ferment
undigest
substrat
reach
larg
intestin
due
damag
small
intestin
mucos
epithelium
respiratori
compens
acidosi
occur
hyperventil
mechan
fall
short
due
inadequ
bicarbon
buffer
base
concentr
affin
sta
receptor
posterior
jejunum
appear
major
site
hypersecret
respons
sta
develop
neonat
enter
colibacillosi
passiv
immun
play
import
role
particular
neonat
infect
prevent
passiv
colostr
lactogen
immun
etec
infect
noninvas
gastrointestin
infect
mucos
ie
lactogen
immun
rather
colostr
ie
system
immun
import
fight
diseas
reason
presenc
high
level
iga
milk
sow
vaccin
expos
pathogen
ecoli
present
environ
piglet
abl
prevent
small
intestin
colon
etec
matern
vaccin
appli
parenter
vaccin
success
particular
gilt
depend
larg
anim
previou
mucos
exposur
etec
piglet
prone
diseas
specif
antibodi
absent
sow
milk
access
suffici
amount
milk
describ
neonat
colibacillosi
ecoli
caus
pwd
enter
anim
ingest
presenc
appropri
predispos
environment
condit
host
factor
prolifer
intestin
caus
diseas
mean
specif
virul
factor
postwean
etec
strain
mostli
possess
fimbria
rare
except
fimbrial
type
sever
variant
subtyp
base
antigen
differ
variant
ab
ac
ad
describ
even
almost
strain
isol
case
pwd
belong
ac
subtyp
two
known
variant
ab
ac
ab
commonli
associ
oedema
diseas
od
strain
ac
pwd
strain
nonfimbri
adhesin
identifi
adhesin
involv
diffus
adher
aida
associ
etec
strain
recov
wean
pig
pwd
evid
caus
involv
diarrhoea
experiment
induc
colostrumdepriv
newborn
piglet
stb
encod
e
coli
howev
role
aida
colibacillosi
pig
remain
elucid
postwean
etec
strain
produc
one
known
follow
enterotoxin
heat
stabl
enterotoxin
sta
stb
heatlabil
enterotoxin
lt
enteroaggreg
ecoli
heatstabl
enterotoxin
mechan
action
sta
describ
neonat
colibacillosi
stb
alter
cgmp
describ
sta
show
differ
mechan
action
bind
stb
receptor
lead
uptak
ca
cell
induc
duoden
jejun
secret
water
electrolyt
vivo
signific
accumul
na
cl
occur
intralumin
follow
stb
intox
addit
stb
stimul
bicarbon
secret
lt
part
import
group
toxin
toxin
famili
two
subtyp
lt
lti
ltii
describ
differ
lti
ltii
larg
due
dissimilar
b
subunit
lti
divid
ltih
ltip
produc
respect
human
porcin
etec
strain
express
lt
also
shown
advantag
colon
promot
adher
etec
vitro
vivo
lt
perman
activ
adenyl
cyclas
cell
basolater
border
lead
hypersecret
electrolyt
water
caus
dehydr
metabol
acidosi
complic
postwean
colibacillosi
limit
circulatori
collaps
occur
report
etec
isol
pig
diarrhoea
howev
role
develop
diarrhoea
elucid
environment
matern
bacteria
quickli
colon
offspr
gut
birth
shape
theonset
healthi
intestin
immun
system
futur
develop
intestin
microbiota
characteris
high
popul
densiti
extens
divers
complex
interact
throughout
gastrointestin
tract
studi
characteris
intestin
microbiota
show
major
bacteri
group
isol
pig
intestin
streptococcu
lactobacillu
prevotella
selenomona
mitsuokella
megasphera
clostridia
eubacteria
bacteroid
fusobacteria
acidodaminococci
enterobacteria
interestingli
report
clear
evid
gut
microbiota
play
import
role
drive
host
metabol
divers
faecal
bacteri
commun
chang
time
differ
pig
depend
subsequ
suscept
postwean
diarrhoea
stomach
proxim
small
intestin
duodenum
contain
rel
low
number
bacteria
bacteriag
ml
content
due
low
ph
andor
rapid
digesta
flow
contrast
distal
small
intestin
harbour
divers
numer
greater
bacteriag
ml
content
bacteri
popul
mean
number
ecoli
biochem
phenotyp
piglet
increas
anim
age
e
coli
popul
pig
faecal
microbiota
farm
environ
dynam
show
high
level
divers
clinic
manifest
enter
colibacillosi
obvious
requir
presenc
pathogen
ecoli
also
environment
chang
recogn
risk
factor
moredo
et
al
demonstr
percentag
etec
posit
nondiarrho
pig
lactat
period
nurseri
phase
finish
popul
data
demonstr
pathogen
also
shed
faec
healthi
anim
alreadi
report
osek
barrier
function
gastrointestin
tract
neonat
piglet
develop
matur
anim
due
higher
ph
stomach
lower
proteolyt
capac
depend
passiv
immun
protect
due
immunolog
immatur
regener
time
small
intestin
epithelium
dayold
piglet
report
day
compar
day
pig
differ
probabl
contribut
suscept
infecti
enter
newborn
piglet
rapid
turnov
enterocyt
consid
defenc
mechan
expuls
infect
cell
taken
togeth
condit
combin
predispos
factor
contribut
neonat
piglet
vulner
etec
enter
infect
wean
chang
intestin
environ
piglet
mainli
due
dietari
chang
result
alter
composit
indigen
flora
divers
ecoli
strain
intestin
flora
usual
high
healthi
pig
enter
colibacillosi
observ
alter
balanc
bacteria
present
normal
intestin
flora
condit
lead
prolifer
domin
pathogen
strain
colon
small
intestin
rapidli
reach
massiv
number
order
g
content
reason
frequent
alway
sampl
collect
diarrhoeic
pig
affect
colibacillosi
allow
isol
pure
cultur
pathogen
ecoli
inform
must
consid
correct
interpret
diagnost
result
particular
evalu
diagnost
find
made
consider
clinic
sign
patholog
lesion
also
take
account
number
isol
pathogen
ecoli
strain
belong
identifi
pathotyp
virotyp
diagnosi
neonat
postwean
enter
colibacillosi
includ
combin
differ
diagnost
procedur
start
observ
clinic
sign
gross
lesion
follow
appropri
bacteriolog
investig
type
isol
bacteri
strain
neonat
diarrhoea
due
enterotoxigen
ecoli
observ
commonli
piglet
age
day
life
gener
endem
condit
litter
firstpar
sow
could
involv
due
lack
protect
passiv
immun
pwd
due
ecoli
commonli
observ
week
wean
although
except
record
week
wean
etec
sustain
neonat
diarrhoea
larg
quantiti
wateri
creami
consist
scour
observ
distinct
smell
often
white
yellow
colour
case
postwean
colibacillosi
due
etec
usual
character
yellowish
grey
slightli
pink
wateri
diarrhoea
characterist
smell
gener
last
one
week
fig
affect
pig
usual
depress
reduc
appetit
rough
sticki
wet
haircoat
sudden
death
occur
particularli
start
outbreak
dead
pig
usual
dehydr
sunken
eye
small
intestin
usual
dilat
slightli
oedemat
hyperaem
fig
stomach
usual
dilat
full
clot
milk
dri
feed
neonat
post
wean
colibacillosi
respect
show
hyperaemia
fundu
fig
mesenter
lymphnod
enlarg
commonli
hyperaem
lesion
even
pathognomon
suggest
enter
colibacillosi
reason
necropsi
case
neonat
postwean
colibacillosi
help
pathologist
choic
subsequ
laboratori
examin
effect
approach
select
number
untreat
pig
suffer
diarrhoea
less
h
human
euthan
perform
accur
necropsi
order
evalu
gross
lesion
evalu
small
intestin
colon
ileocaec
valv
mesenter
lymphnod
collect
sampl
unopen
segment
small
intestin
particular
ileum
jejunum
larg
intestin
end
tie
taken
sent
laboratori
fresh
sampl
bacteriolog
investig
fix
buffer
formalin
histolog
bacteriolog
examin
request
isol
pathogen
e
coli
strain
involv
outbreak
quantif
pure
cultur
type
evalu
sensit
antibiot
fig
fresh
sampl
store
arriv
laboratori
less
h
recent
spontan
dead
anim
also
use
microbiolog
analysi
sinc
autolysi
gut
death
occur
promptli
tissu
obtain
anim
h
death
usual
suitabl
histopatholog
analys
pig
show
characterist
clinic
sign
enter
colibacillosi
euthan
recent
dead
pig
avail
advis
collect
faec
directli
anim
soil
rectal
swab
pig
fig
definit
diagnosi
requir
combin
sever
investig
includ
quantit
bacteriolog
identif
virul
factor
usual
pcr
histopatholog
complementari
analysi
order
integr
interpret
microscop
lesion
observ
pathogen
detect
diagnost
tree
diagnost
criteria
follow
diagnosi
enter
colibacillosi
report
fig
diagnosi
enter
colibacillosi
base
bacteriolog
examin
sampl
lumin
content
first
choic
rectal
swab
sampl
inocul
onto
blood
agar
mcconckey
agar
media
select
enterobatteriacea
hektoen
agar
select
media
allow
differenti
lactos
ferment
ecoli
lactos
nonfer
gram
neg
enter
bacilli
coloni
solid
media
reach
full
size
within
day
incub
vari
smooth
rough
mucoid
characterist
coloni
grown
blood
agar
lactos
ferment
select
media
give
first
diagnost
indic
particular
presenc
haemolyt
coloni
neonat
diarrhoea
pwd
often
use
rapid
tool
diagnosi
etec
diarrhoea
fig
gener
term
etec
isol
case
neonat
colibacillosi
appear
haemolyt
etec
posit
nonhaemolyt
etec
coloni
blood
agar
plate
etec
isol
case
pwd
mostli
haemolyt
etec
even
nonhaemolyt
strain
observ
recent
studi
author
report
ecoli
strain
isol
case
pwd
character
etec
haemolyt
case
remain
nonhaemolyt
etec
isol
haemolyt
activ
consist
test
recov
franc
itali
germani
share
virotyp
sta
stb
detect
pathogen
strain
justifi
diseas
everi
case
import
consid
e
coli
pathotyp
cours
also
isol
gut
habitat
healthi
host
report
evalu
diagnost
find
therefor
made
consider
clinic
patholog
observ
coupl
quantif
isol
pathogen
ecoli
reason
high
concentr
pathogen
ecoli
pure
nearli
pure
cultur
isol
small
intestin
ileum
jejunum
indic
enter
colibacillosi
sinc
almost
etec
haemolyt
presenc
pure
cultur
haemolyt
coloni
use
presumpt
diagnosi
neonat
colibacillosi
interpret
bacteriolog
neg
result
anim
treat
antibiot
unreli
requir
repeat
examin
untreat
pig
identif
virul
gene
encod
fimbria
toxin
isol
strain
crucial
ascertain
role
clinic
problem
observ
current
diagnost
routin
genotyp
analysi
polymeras
chain
reaction
pcr
detect
gene
encod
virul
factor
perform
mani
laboratori
character
isol
strain
primer
recognis
gene
encod
toxin
sta
stb
lt
fimbria
etec
outer
membran
protein
eae
intimin
enteropathogen
ecoli
epec
toxin
stec
ecoli
strain
involv
oedema
diseas
strain
avail
use
perform
pcr
assay
daili
routin
diagnost
interestingli
certain
strain
produc
enterotoxin
toxin
strain
classifi
etec
rather
stec
sinc
produc
clinic
pwd
oedema
diseas
use
end
point
pcr
direct
identif
virul
factor
sampl
diseas
pig
without
perform
semiquantit
bacteriolog
type
individu
isol
make
interpret
difficult
unreli
diagnost
approach
allow
quantif
pathogen
give
mix
detect
virul
factor
belong
differ
ecoli
strain
present
sampl
result
fals
combin
factor
addit
exclud
similar
gene
virul
factor
intestin
enterobacteriacea
might
detect
exampl
studi
perform
bacteria
isol
case
diarrhoea
children
mexico
show
st
toxin
gene
one
strain
identifi
morganii
ident
st
toxin
gene
e
coli
presenc
gene
encod
lt
toxin
previous
report
morganii
obtain
stool
sampl
travel
diarrhoea
develop
quantit
pcr
assay
qpcr
becom
feasibl
option
diagnosi
alon
combin
bacteriolog
colleagu
report
sensit
qpcr
higher
compar
cultiv
e
coli
e
coli
faecal
specimen
pig
diarrhoea
sampl
posit
andor
pathogen
e
coli
detect
cultiv
cfug
e
coli
andor
e
coli
detect
correl
cultiv
high
number
potenti
pathogen
e
coli
even
quantif
pathogen
ecoli
use
qpcr
repres
promis
diagnost
method
enter
colibacillosi
semiquantit
bacteriolog
fundament
import
perform
isol
antimicrobi
suscept
test
ecoli
strain
respons
outbreak
usual
outbreak
posit
ecoli
tend
involv
one
strain
one
time
even
mix
infect
isol
differ
virotyp
outbreak
observ
case
one
virotyp
probabl
predomin
given
outbreak
reason
would
appropri
type
isol
obtain
differ
pig
involv
outbreak
quantit
bacteriolog
examin
compat
cost
examin
order
determin
one
virotyp
involv
outbreak
enter
colibacillosi
exampl
might
advis
test
sampl
repres
pig
diarrhoea
type
isol
previous
chosen
cultur
biochem
characterist
although
approach
give
absolut
result
certainli
increas
reliabl
result
obtain
studi
perform
european
herd
pwd
outbreak
follow
protocol
sampl
report
show
mix
infect
etec
observ
case
data
publish
fig
pathogen
ecoli
may
also
identifi
serotyp
antigen
cell
wall
lp
sinc
small
number
specif
group
associ
diseas
tabl
complet
serotyp
h
flagellar
protein
antigen
antigen
addit
identif
k
antigen
capsular
polysaccharid
standard
method
definit
serotyp
gener
carri
refer
laboratori
differ
clone
within
serogroup
may
evolv
acquir
differ
virul
gene
result
clonal
variat
associ
particular
region
countri
exampl
etec
serogroup
associ
worldwid
fimbria
typic
caus
pwd
australia
od
europ
predomin
serogroup
associ
pwd
pig
worldwid
tabl
histopatholog
formalinfix
paraffin
embed
tissu
ileum
jejunum
larg
intestin
includ
use
addit
investig
definit
diagnosi
colibacillosi
piglet
suffer
neonat
enter
colibacillosi
criteria
method
use
identif
ecoli
strain
isol
case
neonat
postwean
colibacillosi
report
tabl
enter
diseas
outbreak
pig
frequent
multifactori
focus
diagnosi
subsequ
control
strategi
without
take
account
possibl
differenti
diagnos
multipl
agent
involv
misguid
practition
diagnost
evalu
neonat
postwean
colibacillosi
requir
similar
standard
diagnost
procedur
diagnost
pathway
kept
easi
lesion
observ
necropsi
strongli
suggest
case
enter
colibacillosi
bacteriolog
usual
easili
confirm
suspect
given
record
patholog
lesion
diarrhoea
prewean
piglet
probabl
straightforward
identifi
treat
prevent
postwean
diarrhoea
particular
etec
neonat
diarrhoea
must
differenti
caus
diarrhoea
clostridium
difficil
clostridium
perfrigen
type
c
enter
coronaviru
tgev
pedv
rotaviru
group
b
c
piglet
older
day
coccidiosi
due
isospora
sui
also
consid
tabl
etec
pwd
differenti
caus
diarrhoea
alreadi
describ
piglet
epec
enter
coronaviru
tgev
pedv
rotaviru
group
b
c
salmonellosi
prolif
enteropathi
due
lawsonia
intracellulari
brachyspira
spp
tabl
effect
diarrhoea
pig
affect
enter
colibacillosi
loss
liquid
lead
dehydr
anim
administr
salin
solut
rehydr
essenti
mani
case
pig
repres
particular
problem
rehydr
sinc
intraven
rout
impract
subcutan
administr
intraperiton
inject
use
volum
infus
limit
uptak
uncertain
fluid
therapi
consist
electrolyt
replac
solut
contain
glucos
given
oral
use
treatment
dehydr
metabol
acidosi
pig
affect
colibacillosi
studi
rat
clinic
studi
children
shown
oral
rehydr
solut
low
osmol
promot
intestin
fluid
absorpt
benefici
effect
cours
diarrhoea
feed
contain
ppm
zinc
reduc
diarrhoea
mortal
improv
growth
investig
show
zinc
oxid
reduc
bacteri
adher
etec
block
bacteri
invas
prevent
increas
tight
junction
permeabl
modul
cytokin
gene
express
zinc
poorli
absorb
becom
highli
concentr
manur
implic
term
environment
pollut
therapeut
use
zinc
current
debat
gener
term
bacteria
anim
may
develop
resist
zn
well
heavi
metal
cu
resist
gene
zn
often
locat
plasmid
may
transfer
bacteria
intraand
interspeci
exposur
trace
metal
may
also
contribut
antibiot
resist
even
absenc
antibiot
zn
supplement
anim
feed
may
increas
proport
multiresist
e
coli
gut
microbiota
sever
studi
focus
attent
heavi
metal
use
anim
farm
possibl
mechan
could
promot
spread
antibiot
resist
via
coselect
one
report
associ
zinc
methicillinresist
staphylococcu
aureu
mrsa
denmark
conclud
zinc
compound
may
partli
implic
emerg
mrsa
clone
coselect
mechan
includ
coresist
crossresist
coresist
defin
close
proxim
two
genet
element
encod
resist
sulphonamid
resist
exampl
would
follow
coresist
path
crossresist
evolv
antibacteri
agent
attack
target
instanc
efflux
system
simultan
transport
two
type
antibacteri
agent
exampl
cross
resist
could
done
tetracyclin
zinc
resist
strain
would
also
expel
tetracyclin
use
efflux
system
recent
committe
medicin
product
veterinari
use
cvmp
european
medicin
agenc
ema
conclud
referr
procedur
veterinari
medicin
product
contain
zinc
oxid
administ
oral
foodproduc
speci
committe
adopt
opinion
consensu
conclud
benefit
zinc
oxid
prevent
diarrhoea
pig
outweigh
risk
environ
cvmp
highlight
risk
coselect
resist
associ
use
zinc
oxid
present
time
risk
quantifi
committe
therefor
recommend
refus
grant
market
authoris
withdraw
exist
market
authoris
veterinari
medicin
product
contain
zinc
oxid
treatment
enter
colibacillosi
gener
principl
antimicrobi
therapi
antimicrobi
therapi
requir
mani
case
enter
colibacillosi
besid
use
approach
avoid
infecti
agent
clinic
diseas
antimicrobi
therapi
must
select
reach
therapeut
concentr
intestin
lumen
observ
differ
class
antibiot
antibiot
amoxicillin
combin
contain
amoxicillinclavulan
acid
cephalosporin
ceftiofur
cefquinom
aminoglucosid
apramycin
neomycin
gentamycin
aminocyclitol
spectinomycin
sulphonamid
combin
trimethoprim
trimethoprimsulphametoxazol
fluorochinolon
enrofloxacin
marbofloxacin
danofloxacin
quinolon
flumequin
polymyxin
colistin
sulphat
therapeut
approach
consequ
choic
antibiot
treatment
must
consid
sever
aspect
infect
locat
mainli
small
intestin
antibiot
select
therapi
must
reach
suffici
concentr
small
intestin
empir
treatment
perform
basi
knowledg
individu
herd
local
data
resist
pattern
mani
case
evalu
isol
strain
antimicrobi
suscept
fundament
correct
therapi
outbreak
colibacillosi
frequent
requir
quick
action
therefor
use
antibiot
almost
alway
preced
result
resist
pattern
result
case
right
choic
antibiot
remain
practition
respons
laboratori
give
retrospect
result
basic
inform
laboratori
provid
qualit
suscept
result
bacteri
strain
suscept
intermedi
resist
specif
antibiot
quantit
result
obtain
minim
inhibitori
concentr
mic
may
use
tradit
qualit
result
mic
data
defin
degre
pathogen
suscept
precis
figur
report
exampl
step
initi
manag
reassess
antibiot
therapi
outbreak
enter
colibacillosi
european
countri
netherland
introduc
classif
antibiot
first
second
third
choic
last
resort
kind
approach
describ
burch
et
al
classif
continu
revis
gener
term
first
choic
antibiot
use
clinic
diagnosi
empir
treatment
secondchoic
antibiot
reserv
case
sensit
test
clinic
result
proven
firstchoic
antibiot
effect
thirdchoic
antibiot
third
fourth
gener
cephalosporin
fluorochinolon
macrolid
reserv
lastresort
antimicrobi
option
avail
antibiot
administ
anim
show
clinic
sign
refer
colibacillosi
sick
pig
must
treat
parenter
sinc
eat
drink
littl
practic
mortal
occur
metaphylact
approach
appli
wherein
anim
pen
treat
mortal
observ
guidelin
prudent
use
antimicrobi
veterinari
medicin
publish
offici
journal
european
union
consid
use
metaphylaxi
state
antimicrobi
metaphylaxi
prescrib
real
need
treatment
veterinarian
justifi
document
treatment
basi
clinic
find
develop
diseas
herd
flock
pharmacokineticpharmacodynam
indic
gener
inform
antimicrobi
drug
use
treatment
enter
colibacillosi
efficaci
antimicrobi
therapi
depend
upon
pathogen
abil
respond
antimicrobi
therapi
drug
exposur
characterist
necessari
elicit
target
microbiolog
respons
abil
achiev
necessari
activ
drug
concentr
site
infect
relationship
system
drug
exposur
correspond
clinic
microbiolog
effect
term
pharmacokineticspharmacodynam
pkpd
tabl
pkpd
relationship
turn
dictat
dose
dose
frequenc
durat
drug
administr
necessari
achiev
desir
clinic
microbiolog
outcom
pk
compon
describ
handl
drug
host
absorpt
distribut
metabol
elimin
tabl
pd
compon
describ
effect
drug
time
bacteria
site
infect
thu
interplay
pk
pd
reflect
relationship
fluctuat
concentr
biolog
activ
drug
site
infect
reflect
serum
plasma
drug
concentr
versu
effect
target
microbi
pathogen
three
pkpd
indic
propos
allow
predict
antimicrobi
efficaci
ratio
maximum
unbound
free
concentr
mic
cmax
mic
ratio
free
area
concentrationtim
curv
mic
aucmic
percentag
time
thatth
concentr
free
drug
mic
mic
proper
use
pkpd
indic
optim
dosag
turn
increas
possibl
therapeut
success
reduc
toxic
emerg
resist
achiev
high
probabl
microbiolog
clinic
cure
requir
adequ
exposur
bacteria
antimicrobi
agent
exposur
depend
dose
appli
function
differ
pharmacokinet
paramet
drug
bioavail
clearanc
well
pathogen
suscept
eg
mic
interestingli
clinic
breakpoint
use
mic
evalu
calcul
take
account
differ
criteria
mainli
influenc
pkpd
paramet
differ
antimicrobi
approach
base
pharmacokinet
paramet
mic
distribut
use
assess
potenti
dose
treat
system
infect
pathogen
distribut
mic
valu
pathogen
use
estim
rang
dose
necessari
obtain
probabl
therapeut
success
accord
popul
pharmacokinet
data
appropri
dose
antibiot
key
control
clear
bacteria
site
infect
also
limit
antimicrobi
resist
pkpd
indic
mostli
use
target
efficaci
process
dose
select
also
necessari
work
dosag
regimen
optim
frequenc
length
treatment
reach
best
clinic
outcom
lowest
resist
bacteria
select
main
characterist
antimicrobi
use
treatment
enter
colibacillosi
antibiot
penicillin
amoxicillin
cephalosporin
monobactam
carbapenem
prevent
bacteri
cell
wall
form
interf
final
stage
peptidoglycan
synthesi
antibiot
act
bind
cell
wall
synthesi
enzym
known
penicillinbind
protein
pbp
therebi
inhibit
peptidoglycan
synthesi
drug
exert
bactericid
action
caus
lysi
grow
cell
cell
undergo
activ
cellwal
synthesi
amoxicillin
achiev
high
tissu
concentr
well
absorb
intestin
amoxicillin
elimin
almost
entir
kidney
result
high
level
urin
resist
mediat
efflux
mechan
modif
porin
gram
neg
bacteria
prevent
entri
antibiot
clavulan
acid
combin
amoxicillin
ratio
combin
usual
bactericid
combin
potenti
applic
treatment
varieti
infect
swine
caus
plasmidmedi
bacteria
includ
neonat
diarrhoeal
e
coli
clavulan
acid
well
absorb
oral
administr
pharmacokinet
properti
similar
amoxicillin
cephalosporin
advantag
stabil
good
activ
target
protein
pbp
good
abil
penetr
bacteri
cell
wall
fourthgener
cephalosporin
effect
enterobacteriaeca
gramneg
bacteria
resist
earlier
gener
cephalosporin
acquir
resist
cephalosporin
among
safest
antimicrobi
drug
broad
spectrum
antibacteri
activ
second
fourth
gener
drug
may
caus
overgrowth
resist
bacteria
includ
clostridium
difficil
longer
compet
suscept
member
microbi
flora
ceftiofur
sodium
avail
use
swine
treatment
neonat
colibacillosi
fourth
thirdgener
cephalosporin
first
choic
antimicrobi
agent
reserv
use
suscept
test
indic
altern
avail
narrowerspectrum
drug
often
effect
prefer
gener
mechan
resist
reduc
access
pbp
reduc
pbp
bind
affin
destruct
antibiot
express
enzym
bind
hydrolyz
antibacteri
diaminopyrimidin
combin
varieti
sulfonamid
sulfadiazin
sulfamethoxazol
sulfadoxin
fix
ratio
combin
diaminopyrimidin
sulfonamid
inhibit
sequenti
step
synthesi
folic
acid
thu
purin
requir
dna
bacteri
synthesi
interfer
diaminopyrimidin
recycl
tetrahydrofol
dihydrofol
acid
probabl
respons
combin
synergist
interact
combin
wide
margin
safeti
advers
effect
mainli
attribut
sulfonamid
diaminopyrimidin
compon
concentr
tissu
wherea
sulfonamid
compon
move
slowli
plasma
tissu
trimethoprimsulfonamid
combin
use
success
control
wide
varieti
condit
pig
includ
neonat
postwean
colibacillosi
aminoglycosid
antibiot
kanamycin
gentamicin
amikacin
neomycin
larg
molecul
numer
amino
acid
group
make
basic
polyc
highli
ioniz
physiolog
ph
antibacteri
action
aminoglycosid
direct
primarili
aerob
gramneg
bacteria
bactericid
action
aminoglycosid
aerob
gramneg
bacteria
markedli
influenc
ph
activ
alkalin
environ
increas
local
acid
secondari
tissu
damag
bacteri
destruct
may
explain
failur
aminoglycosid
kill
usual
suscept
pathogen
aminoglycosid
poorli
absorb
normal
gastrointestin
tract
well
absorb
im
sc
inject
elimin
entir
renal
excret
glomerular
filtrat
unchang
drug
rapidli
excret
clinic
import
resist
aminoglycosid
caus
plasmidmedi
enzym
broadli
classifi
phosphotransferas
acetyltransferas
adenyltransferas
gentamicin
use
treat
neonat
colibacillosi
piglet
day
day
age
either
singl
im
inject
oral
dose
mg
spectinomycin
aminocyclitol
antibiot
lack
toxic
effect
aminoglycosid
antibiot
limit
applic
readi
develop
resist
spectinomycin
usual
bacteriostat
rel
broadspectrum
drug
bactericid
concentr
time
mic
chromosom
onestep
mutat
highlevel
resist
develop
readili
vivo
vitro
chromosom
resist
strain
show
crossresist
aminoglycosid
pharmacokinet
properti
similar
aminoglycosid
pig
spectinomycin
avail
oral
solut
treatment
colibacillosi
administr
fluoroquinolon
exhibit
rapid
extens
tissu
distribut
hydrophil
natur
low
protein
bind
high
concentr
found
bile
organ
excret
liver
intestin
urinari
tract
fluoroquinolon
predominantli
excret
unchang
drug
urin
glomerular
filtrat
activ
tubular
secret
fluoroquinolon
rel
safe
antimicrobi
drug
administ
therapeut
dose
toxic
effect
mild
gener
limit
gastrointestin
disturb
nausea
vomit
diarrhoea
resist
fluoroquinolon
occur
target
modif
decreas
permeabl
efflux
andor
target
protect
fluoroquinolon
resist
mechan
occur
simultan
within
cell
therebi
lead
high
resist
level
fourth
third
gener
cephalosporin
fluoroquinolon
first
choic
antimicrobi
agent
reserv
use
suscept
test
indic
altern
avail
colistin
polymyxin
e
cation
multicompon
lipopeptid
antibacteri
agent
discov
soon
end
second
world
war
colistin
bactericid
drug
bind
lipopolysaccharid
lp
phospholipid
outer
membran
gram
neg
bacteria
process
result
increas
permeabl
cell
envelop
leakag
cell
content
subsequ
cell
death
colistin
sulphat
approv
product
countri
oral
use
pig
product
control
intestin
infect
caus
enterobacteriacea
polymyxin
well
toler
oral
local
administr
system
use
caus
nephrotox
neurotox
neuromuscular
block
effect
use
colistin
europ
vari
wide
countri
countri
intens
livestock
product
level
usag
mgpcu
eg
denmark
uk
much
higher
mgpcu
itali
spain
due
import
human
medicin
public
health
impact
current
futur
use
colistin
product
anim
discuss
long
time
usual
recommend
dose
therapi
iukg
bw
iukg
bodi
weight
per
day
iukg
administ
interv
noneuropean
countri
use
colistin
authoris
lower
dosag
feed
addit
growth
promot
ecoli
antimicrobi
resist
antimicrobi
resist
sever
antibiot
apramycin
neomycin
trimethoprimsulphametoxazol
colistin
increasingli
observ
etec
strain
caus
pwd
develop
resist
wide
rang
antimicrobi
drug
well
demonstr
trend
resist
etec
strain
antibiot
use
treatment
colibacillosi
pig
nowaday
reason
concern
multidrug
resist
among
etec
isol
describ
recent
increas
tendenc
porcin
etec
express
multidrugresist
phenotyp
difficult
imposs
provid
gener
data
resist
situat
variabl
differ
countri
pig
popul
mainli
depend
antimicrobi
preferenti
use
tabl
report
data
resist
ecoli
strain
differ
antibiot
commonli
use
treatment
colibacilloisi
studi
perform
itali
aim
evalu
trend
resist
etec
isol
period
strain
ecoli
isol
case
porstwean
colibacillosi
test
sever
antibiot
use
disc
diffus
method
studi
intermedi
strain
group
resist
one
isol
show
statist
signific
increas
trend
resist
whole
period
studi
enrofloxacin
flumequin
cefquinom
increas
resist
statist
signific
also
observ
gentamicin
apramycin
trimethoprimsulphametoxazol
resist
enrofloxacin
describ
e
coli
strain
isol
brazil
nearli
isol
case
neonat
colibacillosi
resist
antibiot
fluorochinolon
resist
strongli
correl
quantiti
drug
use
treat
pig
plasmidborn
transfer
fluorochinolon
resist
demonstr
pig
e
coli
strain
high
level
resist
gentamicin
report
e
coli
isol
form
diseas
pig
belgium
poland
spain
resist
gentamicin
aminoglycosid
usual
transmiss
crossresist
gentamicin
apramycin
describ
e
coli
isol
case
pwd
australia
result
resist
streptomycin
spectinomycin
ampicillin
trimethoprimsulphametoxazol
studi
smaller
number
isol
resist
neomycin
apramycin
proport
show
resist
gentamicin
none
isol
resist
enrofloxacin
ceftiofur
studi
perform
korea
show
e
coli
strain
isol
diarrhoeic
pig
multiresist
resist
antibiot
high
level
resist
sever
antibiot
gentamicin
trimethoprimsulphametoxazol
amoxicillin
ampicillin
enrofloxacin
last
year
e
coli
strain
resist
colistin
becom
common
strain
e
coli
acquir
resist
encount
among
pathogen
isol
commonli
pig
suffer
diarrhoea
tabl
resist
colistin
base
mutat
respons
modif
lp
charg
polymyxin
resist
involv
chromosom
mutat
make
resist
mechan
unstabl
incap
spread
bacteria
never
report
via
horizont
gene
transfer
studi
perform
china
antimicrobi
resist
commens
e
coli
food
anim
shown
increas
colistin
resist
describ
emerg
first
transmiss
plasmidmedi
polymyxin
resist
form
gene
easili
transfer
differ
type
bacteria
potenti
lead
rapid
develop
resist
gene
first
detect
ecoli
china
subsequ
also
found
eu
term
antibiot
resist
plasmid
play
central
role
vehicl
resist
gene
captur
subsequ
dissemin
european
commiss
follow
recent
discoveri
new
mechan
resist
bacteria
colistin
caus
gene
request
updat
ema
antimicrobi
advic
ad
hoc
expert
group
ameg
advic
use
colistin
product
anim
within
european
union
advic
publish
juli
expert
group
describ
sever
measur
consid
tackl
problem
summaris
follow
cours
next
year
member
state
reduc
use
colistin
anim
least
target
level
mg
colistinpcu
member
state
also
encourag
set
stricter
nation
target
ideal
mg
colistinpcu
desir
level
reduct
colistin
sale
compens
increas
use
type
antimicrobi
achiev
measur
improv
farm
china
pig
diarrhoea
condit
biosecur
product
cycl
vaccin
livestock
colistin
reclassifi
ad
categori
ameg
classif
system
includ
medicin
reserv
treat
infect
anim
effect
altern
treatment
exist
control
diseas
begin
correct
diagnost
approach
diagnosi
colibacillosi
requir
appropri
sampl
isol
pathogen
standard
diagnost
criteria
includ
evalu
antimicrobi
suscept
therapeut
use
antimicrobi
wide
practic
control
neonat
postwean
colibacillosi
even
mani
countri
prophylact
metaphylact
use
antibiot
still
common
grow
concern
increas
antimicrobi
resist
among
pathogen
e
coli
strain
increas
preval
multiresist
e
coli
strain
diarrhoeic
pig
lead
attent
altern
antibiot
vaccin
probiot
prebiot
addit
manag
practic
even
prevent
approach
shown
promis
efficaci
mani
case
use
antibiot
prefer
treat
control
enter
colibacillosi
nowaday
concern
increas
phenomenon
antimicrobi
resist
among
bacteria
isol
product
anim
risk
link
phenomenon
increas
antimicrobi
use
inappropri
exampl
untarget
manner
eg
mass
medic
use
nonsuscept
microorgan
subtherapeut
dose
repeatedli
inappropri
period
time
condit
forc
ration
judici
use
antibiot
